Accendra Health Inc (ACH) Stock Price, Quote & News

Company Profile

Accendra Health, Inc., together with its subsidiaries, operates as a healthcare solutions company in the United States. It offers a range of products and services for in-home care and delivery for diabetes treatment; home respiratory therapy, including home oxygen and non-invasive ventilation services; obstructive sleep apnea treatment, such as continuous positive airway pressure and bi-level positive airway pressure devices, and patient support services. The company also supplies other home med...

Industry: Medical Distribution

Sector: Healthcare

Phone: (804) 277-4304

Website: www.accendrahealth.com

Address:

4435 Waterfront Drive, Suite 300, Glen Allen, United States

Faizan9449 Aug. 18 at 7:29 PM

$ACH

0 · Reply

PLATINUM_TRADES Aug. 18 at 7:13 PM

$ACH No excuses....if you'd rather slave at a job for it that's ok.... I like it the easy way....awesome alert here onrhr adds.... I got others coming for tomorrow.... Break $1.10 for more here 🪭🪭🪭🪭

1 · Reply

FinDic Aug. 17 at 1:02 PM

$ACH Just started a very small position in the premarket. This is positive news in the short term that buys them at least a few more quarters of liquidity and relieves short term pressure of BK. https://finance.yahoo.com/markets/stocks/articles/accendra-health-drops-equity-issuance-122915500.html

0 · Reply

Faizan9449 Aug. 17 at 12:49 PM

$ACH

0 · Reply

elmono Aug. 14 at 11:37 PM

$ACH inevitable

0 · Reply

Ozyil Aug. 14 at 7:32 PM

$ACH at what price target is bottomed out for dip buy?

0 · Reply

MSG8898 Aug. 14 at 7:16 PM

$ACH on top of that, they still have 5% of the old company. They should immediately sell that stake and announce a bb programme, just the way Embecta did when anyone was screaming a potential BK ahead.

0 · Reply

MSG8898 Aug. 14 at 7:01 PM

$ACH a bit akward. My research estimates around 100-110M of NOL benefit plus deferred interest future savings (76+34) max. If a PE group steps in, they could scoop up a good company with about 2.45B in sales for 870M, paying down around 720M in debt, and 2$ per share (for a buyout price of 150M), with a total fiscal benefit of 100M on future profits. It just doesn't add up, leaving the new company with 1B of debt, 2.45B in sales, and the fiscal benefit.

0 · Reply

MSG8898 Aug. 14 at 1:48 PM

$ACH buying more. I wonder what shorts will do monday when they'll need to cover and noone will be selling in order to have the Aug. 20th timeline set. Lol.

0 · Reply

Aboudouh Aug. 14 at 12:16 PM

$ACH bankruptcy is waiting in a corner Bk sooner or later

1 · Reply

Accendra Health updates capital allocation, CEO succession plans

Aug 17, 2026, 6:30 AM EDT - 2 days ago

Accendra Health Updates on Capital Allocation and CEO Succession Timing Plans

2026-08-17T07:52:55.000Z - 2 days ago

Accendra Health price target lowered to $1.50 from $4.50 at UBS

2026-08-11T13:25:12.000Z - 7 days ago

Accendra Health price target lowered to $1.30 from $2.70 at BofA

2026-08-11T09:10:09.000Z - 8 days ago

Accendra Health downgraded to Neutral from Outperform at Baird

2026-08-10T20:30:29.000Z - 8 days ago

Accendra Health downgraded to Neutral from Buy at Citi

Aug 10, 2026, 8:00 AM EDT - 9 days ago

Accendra Health Earnings Call Transcript: Q2 2026

Aug 10, 2026, 8:00 AM EDT - 9 days ago

Accendra Health Slides: Q2 2026

Aug 10, 2026, 8:00 AM EDT - 9 days ago

Accendra Health Earnings release: Q2 2026

Aug 10, 2026, 8:00 AM EDT - 9 days ago

Accendra Health Quarterly report: Q2 2026

2026-08-10T10:55:43.000Z - 9 days ago

Accendra Health adopts Section 382 Rights Agreement

2026-08-10T10:51:14.000Z - 9 days ago

Accendra Health reports Q2 adjusted EPS (19c), consensus (9c)

2026-08-10T10:50:27.000Z - 9 days ago

Accendra Health lowers FY26 revenue view to $2.45B-$2.55B from $2.55B-$2.65B

Aug 10, 2026, 6:50 AM EDT - 9 days ago

Accendra Health Announces Adoption of Tax Asset Preservation Plan To Protect Long Term Shareholder Value

Aug 10, 2026, 6:45 AM EDT - 9 days ago

Accendra Health Reports Second Quarter 2026 Financial Results

2026-08-10T10:42:35.000Z - 9 days ago

Accendra Health’s President and CEO Ed Pesicka intends to retire after 2026

Aug 10, 2026, 6:30 AM EDT - 9 days ago

Accendra Health's Ed Pesicka Announces Intent to Retire; Board of Directors Has Begun Successor Search

Jul 27, 2026, 9:15 AM EDT - 22 days ago

Accendra Health Announces Second Quarter 2026 Earnings Release Date and Conference Call

2026-07-24T10:40:25.000Z - 26 days ago

Accendra Health price target lowered to $4.50 from $5 at Citi

2026-07-15T20:20:20.000Z - 4 weeks ago

Accendra Health files $200M mixed securities shelf

Jul 15, 2026, 8:00 AM EDT - 5 weeks ago

Accendra Health Registration statement: Registration filing

Jun 23, 2026, 9:15 PM EDT - 2 months ago

Accendra Health Announces Expiration and Final Results of Offers and Consent Solicitations

Jun 10, 2026, 6:30 AM EDT - 2 months ago

Accendra Health Announces Early Results of Offers and Consent Solicitations

May 22, 2026, 4:01 PM EDT - 3 months ago

Accendra Health Announces Offers and Consent Solicitations

May 14, 2026, 9:00 AM EDT - 3 months ago

Accendra Health Transcript: AGM 2026

2026-05-12T14:31:15.000Z - 3 months ago

Accendra Health price target raised to $4.50 from $3 at UBS

2026-05-12T11:40:36.000Z - 3 months ago

Accendra Health price target raised to $6 from $5 at Baird

2026-05-12T10:41:20.000Z - 3 months ago

Accendra Health price target raised to $5 from $3.25 at Citi

May 11, 2026, 8:30 AM EDT - 3 months ago

Accendra Health Earnings Call Transcript: Q1 2026

May 11, 2026, 8:30 AM EDT - 3 months ago

Accendra Health Earnings release: Q1 2026

May 11, 2026, 8:30 AM EDT - 3 months ago

Accendra Health Slides: Q1 2026

May 11, 2026, 8:30 AM EDT - 3 months ago

Accendra Health Quarterly report: Q1 2026

2026-05-11T11:18:41.000Z - 3 months ago

Accendra Health reports Q1 EPS (4c) vs. 29c last year

2026-05-11T11:16:27.000Z - 3 months ago

Accendra Health backs FY26 guidance for net revenue and adjusted EBITDA

May 11, 2026, 6:30 AM EDT - 3 months ago

Accendra Health Reports First Quarter 2026 Financial Results and Announces Comprehensive Balance Sheet Optimization Transaction

May 1, 2026, 5:00 PM EDT - 3 months ago

Accendra Health Announces First Quarter 2026 Earnings Release Date and Conference Call

Apr 2, 2026, 8:00 AM EDT - 4 months ago

Accendra Health Proxy statement: Proxy filing

Apr 2, 2026, 8:00 AM EDT - 4 months ago

Accendra Health Proxy statement: Proxy filing

2026-02-23T11:47:57.000Z - 6 months ago